|
| | Publication Year | Title | Author(s) |
| 21 | Jun-2022 | Integrated clinical and genomic evaluation of guadecitabine (SGI-110) in peripheral T-cell lymphoma. | Wong, Jonathan; Gruber, Emily; Maher, Belinda; Waltham, Mark; Sabouri-Thompson, Zahra; Jong, Ian; Luong, Quinton; Levy, Sidney; Kumar, Beena; Brasacchio, Daniella; Jia, Wendy; So, Joan; Skinner, Hugh; Lewis, Alexander; Hogg, Simon J; Vervoort, Stephin; DiCorleto, Carmen; Uhe, Micheleine; Gamgee, Jeanette; Opat, Stephen; Gregory, Gareth P; Polekhina, Galina; Reynolds, John; Hawkes, Eliza A ; Kailainathan, Gajan; Gasiorowski, Robin; Kats, Lev M; Shortt, Jake |
| 22 | 16-May-2022 | Toxicity associated with high-dose intravenous methotrexate for hematological malignancies. | Wight, Joel C ; Ku, Matthew; Garwood, Melissa; Carradice, Duncan; Lasica, Masa; Keamy, Louise; Hawkes, Eliza A ; Grigg, Andrew P |
| 23 | 10-Feb-2022 | Limited-stage Diffuse Large B-cell Lymphoma. | Hawkes, Eliza A ; Barraclough, Allison ; Sehn, Laurie H |
| 24 | Nov-2021 | Simplified Geriatric Assessment in Older Patients With Diffuse Large B-Cell Lymphoma: The Prospective Elderly Project of the Fondazione Italiana Linfomi. | Merli, Francesco; Luminari, Stefano; Tucci, Alessandra; Arcari, Annalisa; Rigacci, Luigi; Hawkes, Eliza A ; Chiattone, Carlos S; Cavallo, Federica; Cabras, Giuseppina; Alvarez, Isabel; Fabbri, Alberto; Re, Alessandro; Puccini, Benedetta; Barraclough, Allison ; Delamain, Marcia Torresan; Ferrero, Simone; Usai, Sara Veronica; Ferrari, Angela; Cencini, Emanuele; Pennese, Elsa; Zilioli, Vittorio Ruggero; Marino, Dario; Balzarotti, Monica; Cox, Maria Christina; Zanni, Manuela; Di Rocco, Alice; Lleshi, Arben; Botto, Barbara; Hohaus, Stefan; Merli, Michele; Sartori, Roberto; Gini, Guido; Nassi, Luca; Musuraca, Gerardo; Tani, Monica; Bottelli, Chiara; Kovalchuk, Sofia; Re, Francesca; Flenghi, Leonardo; Molinari, Annalia; Tarantini, Giuseppe; Chimienti, Emanuela; Marcheselli, Luigi; Mammi, Caterina; Spina, Michele |
| 25 | 20-Oct-2021 | Diagnosis, management and follow up of peripheral T cell lymphomas: A Consensus Practice Statement from the Australasian Lymphoma Alliance. | Hapgood, G; Latimer, M; Lee, Sze Ting ; Kuss, B; Lade, S; Tobin, J W D; Purtill, D; Campbell, B A; Prince, H M; Hawkes, Eliza A ; Shortt, J; Radeski, D |
| 26 | 18-Sep-2021 | Correction to: Exploration of motivation to participate in a study of cancer-related cognitive impairment among patients with newly diagnosed aggressive lymphoma: a qualitative sub-study. | Gates, Priscilla ; Dhillon, Haryana; Gough, Karla; Wilson, Carlene J ; Hawkes, Eliza A ; Scudder, Lindsay; Cushion, Tania; Krishnasamy, Meinir |
| 27 | 15-Sep-2021 | The Magnolia Trial: Zanubrutinib, A Next-Generation Bruton Tyrosine Kinase Inhibitor, Demonstrates Safety and Efficacy in Relapsed/Refractory Marginal Zone Lymphoma. | Opat, Stephen; Tedeschi, Alessandra; Linton, Kim; McKay, Pamela; Hu, Bei; Chan, Henry; Jin, Jie; Sobieraj-Teague, Magdalena; Zinzani, Pier Luigi; Coleman, Morton; Thieblemont, Catherine; Browett, Peter; Ke, Xiaoyan; Sun, Mingyuan; Marcus, Robert; Portell, Craig A; Ardeshna, Kirit; Bijou, Fontanet; Walker, Patricia; Hawkes, Eliza A ; Mapp, Sally; Ho, Shir-Jing; Talaulikar, Dipti; Zhou, Ke-Shu; Co, Melannie; Li, Xiaotong; Zhou, Wenxiao; Cappellini, Massimo; Tankersley, Chris; Huang, Jane; Trotman, Judith |
| 28 | 8-Jul-2021 | Predicting primary treatment failure using interim FDG-PET scanning in Diffuse large B-cell lymphoma. | Wight, Joel C ; Wai, Shin Hnin; Shen, Edward; Lee, Sze Ting ; Berlangieri, Salvatore U ; Fancourt, Tineke ; Hawkes, Eliza A ; Hannah, Anthony; Leung, Teresa; Chong, Geoffrey |
| 29 | Jul-2021 | Systemic ALCL Treated in Routine Clinical Practice: Outcomes Following First-Line Chemotherapy from a Multicentre Cohort. | Martinez-Calle, Nicolas; Kirkwood, Amy A; Lamb, Maxine; Smith, Alex; Khwaja, Jahanzaib; Manos, Kate ; Shrubsole, Caroline; Gray, Nicola; Lewis, Katharine; Tivey, Ann; Bishton, Mark J; Hawkes, Eliza A ; Ahearne, Matthew J; Osborne, Wendy; Collins, Graham P; Illidge, Timothy; Linton, Kim M; Cwynarski, Kate; Burton, Cathy; Fox, Christopher P |
| 30 | May-2021 | Evolution of eligibility criteria for diffuse large B-cell lymphoma randomised controlled trials over 30 years. | Loh, Zoe ; Salvaris, Ross; Chong, Geoffrey ; Churilov, Leonid ; Manos, Kate ; Barraclough, Allison ; Hawkes, Eliza A |
| 31 | Mar-2021 | Prognostic indices in diffuse large B-cell lymphoma in the rituximab era: an analysis of the UK National Cancer Research Institute R-CHOP 14 versus 21 phase 3 trial. | Gleeson, Mary; Counsell, Nicholas; Cunningham, David; Lawrie, Anthony; Clifton-Hadley, Laura; Hawkes, Eliza A ; McMillan, Andrew; Ardeshna, Kirit M; Burton, Cathy; Chadwick, Nick; Gambell, Joanna; Smith, Paul; Mouncey, Paul; Pocock, Christopher; Radford, John; Davies, John; Turner, Deborah; Kruger, Anton; Johnson, Peter; Linch, David |
| 32 | Mar-2021 | Ibrutinib for central nervous system lymphoma: the Australasian Lymphoma Alliance/MD Anderson Cancer Center experience. | Lewis, Katharine L; Chin, Collin K; Manos, Kate ; Casey, John; Hamad, Nada; Crawford, Julie; Ho, Shir-Jing; Issa, Samar; Grigg, Andrew P ; Wood, Peter; Gandhi, Maher K; Do, Bryan; Nastoupil, Loretta; Hawkes, Eliza A ; Cheah, Chan Y |
| 33 | Feb-2021 | Pralatrexate in relapsed/refractory T-cell lymphoma: a retrospective multicenter study. | Bhurani, Mansi; Admojo, Lorenz; Van Der Weyden, Carrie; Twigger, Robert; Bazargan, Ali; Quach, Hang; Zimet, Allan; Coyle, Luke; Lindsay, Julian; Radeski, Dejan; Hawkes, Eliza A ; Kennedy, Glen; Irving, Ian; Gutta, Naadir; Trotman, Judith; Yeung, James; Dunlop, Lindsay; Hua, Minh; Giri, Pratyush; Yuen, Sam; Panicker, Shyam; Moreton, Susan; Khoo, Liane; Scott, Ashleigh; Kipp, David; McQuillan, Andrew; McCormack, Chris; Dickinson, Michael; Prince, Henry Miles |
| 34 | Feb-2021 | Mycosis fungoides and Sézary syndrome: Australian clinical practice statement. | Bhabha, Friyana K; McCormack, Christopher; Wells, Jillian; Campbell, Belinda A; Newland, Kate; Lade, Stephen; Buelens, Odette; Joske, David; Shortt, Jake; Mapp, Sally; Radeski, Dejan; Hertzberg, Mark; Khot, Amit; Van Der Weyden, Carrie; Khoo, Christine; Hawkes, Eliza A ; Prince, H Miles |
| 35 | Feb-2021 | Use of Ultrasonography Facilitates Noninvasive Evaluation of Lymphadenopathy in a Lymph Node Diagnostic Clinic. | Loh, Zoe ; Hawkes, Eliza A ; Chionh, Fiona; Azad, Arun; Chong, Geoffrey |
| 36 | 2021 | Avelumab in Combination Regimens for Relapsed/Refractory DLBCL: Results from the Phase Ib JAVELIN DLBCL Study. | Hawkes, Eliza A ; Phillips, Tycel; Budde, Lihua Elizabeth; Santoro, Armando; Saba, Nakhle S; Roncolato, Fernando; Gregory, Gareth P; Verhoef, Gregor; Offner, Fritz; Quero, Cristina; Radford, John; Giannopoulos, Krzysztof; Stevens, Don; Thall, Aron; Huang, Bo; Laird, A Douglas; Sandner, Robin; Ansell, Stephen M |
| 37 | 2021 | Exploration of motivation to participate in a study of cancer-related cognitive impairment among patients with newly diagnosed aggressive lymphoma: a qualitative sub-study. | Gates, Priscilla ; Dhillon, Haryana; Gough, Karla; Wilson, Carlene J ; Hawkes, Eliza A ; Scudder, Lindsay; Cushion, Tania; Krishnasamy, Meinir |
| 38 | 10-Dec-2020 | Can PET eradicate irradiation in PMBCL? | Hawkes, Eliza A |
| 39 | Nov-2020 | Routine Blood Tests in Asymptomatic Patients With Indolent Lymphoma Have Limited Ability to Detect Clinically Significant Disease Progression. | Piercey, Oliver A; Loh, Zoe ; Chan, Joanna; Chong, Geoffrey ; Grigg, Andrew P ; Cheema, Steven ; Gill, Gurjot; Whybird, Matthew; Cushion, Tania; Hawkes, Eliza A |
| 40 | 26-Oct-2020 | Caution in Expanding the Use of Abbreviated R-CHOP to Poor-Risk Limited-Stage DLBCL. | Hawkes, Eliza A ; Opat, Stephen; Hertzberg, Mark |
Loading...
2
0
20
0
false
0000-0002-0376-2559